Application of neuroprotectors in severe brain injuries

Abstract

Blood concentration of protein S100 was been decreased with choline-liked neuroprotectors citicoline and choline alfoscerate in clinical trial 52 patients in early day after stroke. Concentration of neuron-specific enolase was been decreased with three month mildronat therapy in blood of 16 patients with traumatic brain injury. Neuroprotective therapy has stabilization of blood-brain barrier as result.

Keywords

• ишемический инсульт
• черепно-мозговая травма
• белок s100
• нейронспецифическая енолаза
• цитиколин
• холина альфосцерат
• милдронат